Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
fda
2
×
life sciences
national blog main
san diego blog main
san diego top stories
2
×
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
clinical trials
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
dyne therapeutics
esperion
europe blog main
europe top stories
financing
gilead sciences
immunomedics
incyte
indiana blog main
indiana top stories
What
developing
2
×
ipo
medicines
activity
approvals
bio
biogen
brings
clamped
company
covid
delays
disorders
drug
dyne
dyne’s
economic
fast
fda
genetic
including
isn’t
lot
million
muscle
muscular
new
oric’s
preclinical
raised
rare
roundup
showing
spread
stage
testing
therapeutics
topped
upsized
work
Language
unset
Current search:
developing
×
fda
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
